BioStem Technologies (OTC: BSEM)
Barry Hassett is an experienced marketing professional with a significant background in the healthcare sector. Currently serving as the Senior Vice-President of Marketing at BioStem Technologies, Barry has also held the position of Principal at BH Healthcare Solutions. Prior roles include Vice President of Marketing at both TissueTech, Inc. and Carticept Medical, Inc. Barry's expertise encompasses strategic marketing initiatives and business development within the industry.
This person is not in any teams
This person is not in any offices
BioStem Technologies (OTC: BSEM)
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.